Most With High-Risk Alzheimer’s Gene Develop Biologically Defined AD

Patients with two copies of the Alzheimer’s high-risk gene apolipoprotein e4 (APOE4) are more likely to develop the biological characteristics that define Alzheimer’s disease, a finding that could have important implications in drug design and clinical trials.
Source: Drug Industry Daily